All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
IHE total return snapshot: IHE returned +44.65% over the past year and +8.48% YTD, with dividends reinvested. Since May 5, 2006, IHE is up +635.73% in nominal total return, or +10.46%/yr, and is currently ā0.96% below its total-return high on May 28, 2026.
| Fri 2006-05-05š¬ to Fri 2026-05-29 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| IHE × |
+8.48%
2026-05-29 |
+44.65%
2026-05-29 |
||||
| iShares U.S. Pharmaceuticals ETF NYSE Exchange-Traded Fund | ||||||
| Fri 2006-05-05š¬ to Fri 2026-05-29 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IHE × |
+635.73%
+10.46%/yr |
+10.50%/yr
(R2=0.904) |
||||
| iShares U.S. Pharmaceuticals ETF NYSE Exchange-Traded Fund | ||||||
| Fri 2006-05-05š¬ to Fri 2026-05-29 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| IHE × |
$10,000.00
2006-05-05 |
$73,573.18
2026-05-29 |
||||
| iShares U.S. Pharmaceuticals ETF NYSE Exchange-Traded Fund | ||||||
| Year | IHE |
|---|---|
| 2026 (YTD) | +8.48% |
| 2025 | +31.69% |
| 2024 | +8.13% |
| 2023 | +1.06% |
| 2022 | ā4.87% |
| 2021 | +13.07% |
| 2020 | +13.66% |
| 2019 | +15.47% |
| 2018 | ā7.76% |
| 2017 | +10.64% |
| 2016 | ā11.75% |
| 2015 | +8.81% |
| 2014 | +29.90% |
| 2013 | +40.59% |
| 2012 | +13.38% |
| 2011 | +20.94% |
| 2010 | +12.71% |
| 2009 | +30.11% |
| 2008 | ā14.92% |
| 2007 | +2.37% |
| 2006 | +6.50% |
| Fri 2006-05-05š¬ to Fri 2026-05-29 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| IHE × |
ā0.96%
from 2026-05-28 peak |
ā38.20%
2009-03-05 from 2007-05-22 peak |
||||
| iShares U.S. Pharmaceuticals ETF NYSE Exchange-Traded Fund | ||||||
| Period ending Fri 2026-05-29 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| IHE × | +44.65% |
+46.46% +21.04%/yr |
+68.35% +18.90%/yr |
+62.80% +10.23%/yr |
+120.30% +8.21%/yr |
|
| iShares U.S. Pharmaceuticals ETF NYSE Exchange-Traded Fund | ||||||
